NEXENTIS TECHNOLOGIES INC. Allowance for Doubtful Accounts, Premiums and Other Receivables
NEXENTIS TECHNOLOGIES INC. (NXTS) had Allowance for Doubtful Accounts, Premiums and Other Receivables of $47.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables · last filed 2025-11-13
- 2025-09-30: Allowance for Doubtful Accounts, Premiums and Other Receivables $47.00K.
- 2025-06-30: Allowance for Doubtful Accounts, Premiums and Other Receivables $47.00K.
- 2025-03-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $43.00K.
- 2024-12-31: Allowance for Doubtful Accounts, Premiums and Other Receivables $42.00K.
| Period end | Allowance for Doubtful Accounts, Premiums and Other Receivables | Allowance for Doubtful Accounts, Premiums and Other Receivables as first filed |
|---|---|---|
| 2025-09-30 | $47.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $47.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $43.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $42.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $57.80K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $64.00K 10-K · filed 2025-03-31 | $64.03K 10-K · filed 2024-04-01 |
| 2022-12-31 | $24.26K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $27.45K 10-K · filed 2023-03-27 | |
| 2020-12-31 | $26.55K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $24.70K 10-K · filed 2021-03-29 | |
| 2018-12-31 | $24.62K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |